← Back to patent-cliff list
Albuvirtide
Tier C — Watch / tradeAlbuvirtide
Frontier Biotechnologies Inc.
Originator
2018
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：gp41
Brand：Ai Koning
Indications (approved)：HIV infection
Regional status
US
-
EU
-
China
Approved
2018-05-23
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Albuvirtide?
Approved indications include: HIV infection.
When does the Albuvirtide patent expire?
No public expiry year is available for Albuvirtide yet; this page updates once verified.
How do I get a quote for Albuvirtide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29